D-0096-2018 Class II Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
December 6, 2017
Initiation Date
November 9, 2017
Termination Date
July 3, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,870 bottles

Product Description

Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05

Reason for Recall

Failed Tablet/Capsule Specifications; potential presence of broken tablets.

Distribution Pattern

Nationwide

Code Information

Lot # 39C192, exp 06/2019